Some markers of neuronal damage in cerebrospinal fluid of multiple sclerosis patients in relapse

被引:0
|
作者
Mitosek-Szewczyk, Krystyna [1 ,2 ]
Gordon-Krajcer, Wanda [3 ]
Flis, Dorota [4 ]
Stelmasiak, Zbigniew [1 ]
机构
[1] Med Univ Lublin, Dept Neurol, PL-20954 Lublin, Poland
[2] Med Univ Lublin, Dept Child Neurol, PL-20954 Lublin, Poland
[3] Polish Acad Sci, Mossakowski Med Res Ctr, Dept Neurodegenerat Disorders, Warsaw, Poland
[4] Publ Independent Clin Hosp 4 Lublin, Lublin, Poland
关键词
multiple sclerosis; neurofilament; tau and phospho-tau proteins; S-100B; beta-APP; A beta-amyloid protein; neuron-specific enolase; AMYLOID PRECURSOR PROTEIN; MYELIN BASIC-PROTEIN; NEUROFILAMENT PROTEIN; CEREBRAL-ISCHEMIA; AXONAL DAMAGE; TAU; ACCUMULATION; BRAIN; S-100; EXPRESSION;
D O I
暂无
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
In this paper the performance of cerebrospinal fluid (CSF) protein biomarkers important for monitoring damage of brain astrocytes and neurons for MS is reviewed. We estimated neurofilament, tau and phospho-tau proteins, beta-APP, A beta, S-100B and neuron-specific enolase in CSF of MS patients during relapse. We noted elevation of neurofilament, tau and phospho-tau proteins, S-100B, neuron-specific enolase and c-terminal epitopes of beta-APP; concomitantly decrease of A beta was observed. These CSF biomarkers for MS relapse should reflect the central pathogenic processes in the brain, i.e., axonal and neuronal degeneration.
引用
收藏
页码:191 / 196
页数:6
相关论文
共 50 条
  • [21] 25-Hydroxyvitamin D in cerebrospinal fluid during relapse and remission of multiple sclerosis
    Holmoy, Trygve
    Moen, Stine Marit
    Gundersen, Thomas A.
    Holick, Michael F.
    Fainardi, Enrico
    Castellazzi, Massimiliano
    Casetta, Ilaria
    MULTIPLE SCLEROSIS, 2009, 15 (11): : 1280 - 1285
  • [22] Cerebrospinal fluid from multiple sclerosis patients inactivates neuronal Na+ current
    Koller, H
    Buchholz, J
    Siebler, M
    BRAIN, 1996, 119 : 457 - 463
  • [23] Reduced cerebrospinal fluid BACE1 activity in multiple sclerosis
    Mattsson, N.
    Axelsson, M.
    Haghighi, S.
    Malmestrom, C.
    Wu, G.
    Anckarsater, R.
    Sankaranarayanan, S.
    Andreasson, U.
    Fredrikson, S.
    Gundersen, A.
    Johnsen, L.
    Fladby, T.
    Tarkowski, A.
    Trysberg, E.
    Wallin, A.
    Anckarsater, H.
    Lycke, J.
    Andersen, O.
    Simon, A. J.
    Blennow, K.
    Zetterberg, H.
    MULTIPLE SCLEROSIS JOURNAL, 2009, 15 (04) : 448 - 454
  • [24] Plasmacytoid dendritic cells are increased in cerebrospinal fluid of untreated patients during multiple sclerosis relapse
    Longhini, Ana Leda F.
    von Glehn, Felipe
    Brandao, Carlos Otavio
    de Paula, Rosemeire F. O.
    Pradella, Fernando
    Moraes, Adriel S.
    Farias, Alessandro S.
    Oliveira, Elaine C.
    Quispe-Cabanillas, Juan G.
    Abreu, Cassiana Horta
    Damasceno, Alfredo
    Damasceno, Benito P.
    Balashov, Konstantin E.
    Santos, Leonilda M. B.
    JOURNAL OF NEUROINFLAMMATION, 2011, 8
  • [25] Plasmacytoid dendritic cells are increased in cerebrospinal fluid of untreated patients during multiple sclerosis relapse
    Ana Leda F Longhini
    Felipe von Glehn
    Carlos Otávio Brandão
    Rosemeire FO de Paula
    Fernando Pradella
    Adriel S Moraes
    Alessandro S Farias
    Elaine C Oliveira
    Juan G Quispe-Cabanillas
    Cassiana Horta Abreu
    Alfredo Damasceno
    Benito P Damasceno
    Konstantin E Balashov
    Leonilda MB Santos
    Journal of Neuroinflammation, 8
  • [26] Tau protein concentrations in cerebrospinal fluid of patients with multiple sclerosis
    Jiménez-Jiménez, FJ
    Zurdo, JM
    Hernanz, A
    Medina-Acebrón, S
    de Bostus, F
    Barcenilla, B
    Sayed, Y
    Ayuso-Peralta, L
    ACTA NEUROLOGICA SCANDINAVICA, 2002, 106 (06): : 351 - 354
  • [27] Cerebrospinal fluid measures of disease activity in patients with multiple sclerosis
    Sellebjerg, F
    Christiansen, M
    Nielsen, PM
    Frederiksen, JL
    MULTIPLE SCLEROSIS, 1998, 4 (06): : 475 - 479
  • [28] Cerebrospinal fluid biomarkers of β-amyloid metabolism in multiple sclerosis
    Augutis, Kristin
    Axelsson, Markus
    Portelius, Erik
    Brinkmalm, Gunnar
    Andreasson, Ulf
    Gustavsson, Mikael K.
    Malmestrom, Clas
    Lycke, Jan
    Blennow, Kaj
    Zetterberg, Henrik
    Mattsson, Niklas
    MULTIPLE SCLEROSIS JOURNAL, 2013, 19 (05) : 543 - 552
  • [29] Brain-Specific Cytoskeletal Damage Markers in Cerebrospinal Fluid: Is There a Common Pattern between Amyotrophic Lateral Sclerosis and Primary Progressive Multiple Sclerosis?
    Abdelhak, Ahmed
    Junker, Andreas
    Brettschneider, Johannes
    Kassubek, Jan
    Ludolph, Albert C.
    Otto, Markus
    Tumani, Hayrettin
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2015, 16 (08) : 17565 - 17588
  • [30] EVIDENCE OF EARLY NEURONAL DAMAGE IN THE SERUM OF MULTIPLE SCLEROSIS PATIENTS
    Zaprianova, Emilia
    Sergeeva, Svetlana S.
    Sotnikov, Oleg S.
    Deleva, Denislava
    Sultanov, Borislav
    Kolyovska, Vera
    Krasnova, Tatiana V.
    COMPTES RENDUS DE L ACADEMIE BULGARE DES SCIENCES, 2010, 63 (03): : 447 - 454